中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (3): 201-208.doi: 10.35541/cjd.20230711
中国医学科学院皮肤病医院 中国疾病预防控制中心性病控制中心 中华医学会皮肤性病学分会性病学组 中国康复医学会皮肤病康复专业委员会
收稿日期:2023-12-04
修回日期:2024-01-08
发布日期:2024-03-04
通讯作者:
苏晓红；王千秋；刘全忠
E-mail:suxh@ncstdlc.org; wangqq@ncstdlc.org; liuquanzhong@tmu.edu.cn
基金资助:Hospital for Skin Diseases, Chinese Academy of Medical Sciences; National Center for STD Control, Chinese Center for Disease Control and Prevention; Venereology Group, Chinese Society of Dermatology; Chinese Association Rehabilitation of Dermatology
Received:2023-12-04
Revised:2024-01-08
Published:2024-03-04
Contact:
Su Xiaohong; Wang Qianqiu; Liu Quanzhong
E-mail:suxh@ncstdlc.org; wangqq@ncstdlc.org; liuquanzhong@tmu.edu.cn
Supported by:摘要： 【摘要】 生殖支原体可引起尿道炎、宫颈炎和盆腔炎等泌尿生殖道感染，并且与早产相关。因培养困难，诊断依赖于核酸检测，其耐药性增加导致临床治疗面临巨大挑战。中国医学科学院皮肤病医院、中国疾病与预防控制中心性病控制中心、中华医学会皮肤性病学分会和中国康复医学会皮肤病康复专业委员会组织国内有关专家依据国际最新生殖支原体诊疗指南及国内外研究进展，围绕生殖支原体感染病原学、流行病学、临床表现、实验室检测、诊断与治疗、随访和判愈、性伴管理、预防等内容进行充分讨论，形成此共识，旨在提高我国临床医师对生殖支原体感染的认识和诊疗水平。
中国医学科学院皮肤病医院 中国疾病预防控制中心性病控制中心 中华医学会皮肤性病学分会性病学组 中国康复医学会皮肤病康复专业委员会. [开放获取] 中国生殖支原体感染诊疗专家共识（2024）[J]. 中华皮肤科杂志, 2024,57(3):201-208. doi:10.35541/cjd.20230711
Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection （2024）[J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208.doi:10.35541/cjd.20230711
| ［1］ | Taylor⁃Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly［J］. Clin Microbiol Rev, 2011,24（3）:498⁃514. doi: 10.1128/CMR.00006⁃11. |
| ［2］ | Horner PJ, Martin DH. Mycoplasma genitalium infection in men［J］. J Infect Dis, 2017,216（suppl_2）:S396⁃S405. doi: 10.1093/infdis/jix145. |
| ［3］ | Lis R, Rowhani⁃Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta⁃analysis［J］. Clin Infect Dis, 2015,61（3）:418⁃426. doi: 10.1093/cid/civ312. |
| ［4］ | Barker EK, Malekinejad M, Merai R, et al. Risk of human immunodeficiency virus acquisition among high⁃risk hetero⁃sexuals with nonviral sexually transmitted infections: a systematic review and meta⁃analysis［J］. Sex Transm Dis, 2022,49（6）:383⁃397. doi: 10.1097/OLQ.0000000000001601. |
| ［5］ | Manhart LE, Mostad SB, Baeten JM, et al. High Mycoplasma genitalium organism burden is associated with shedding of HIV⁃1 DNA from the cervix［J］. J Infect Dis, 2008,197（5）:733⁃736. doi: 10.1086/526501. |
| ［6］ | US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019［EB］. Atlanta: Department of Health and Human Services, 2019. |
| ［7］ | Jensen JS, Cusini M, Gomberg M, et al. 2016 European guideline on Mycoplasma genitalium infections［J］. J Eur Acad Dermatol Venereol, 2016,30（10）:1650⁃1656. doi: 10.1111/jdv.13849. |
| ［8］ | Jensen JS, Cusini M, Gomberg M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections［J］. J Eur Acad Dermatol Venereol, 2022,36（5）:641⁃650. doi: 10. 1111/jdv.17972. |
| ［9］ | 王千秋, 刘全忠, 徐金华, 等. 性传播疾病临床诊疗与防治指南［M］. 2版. 上海: 上海科学技术出版社, 2020. |
| ［10］ | Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations［J］. BMJ, 2008,336（7650）:924⁃926. doi: 10. 1136/bmj.39489.470347.AD. |
| ［11］ | Dehon PM, McGowin CL. The immunopathogenesis of Mycoplasma genitalium infections in women: a narrative review［J］. Sex Transm Dis, 2017,44（7）:428⁃432. doi: 10.1097/OLQ. 0000000000000621. |
| ［12］ | Fraser CM, Gocayne JD, White O, et al. The minimal gene complement of Mycoplasma genitalium［J］. Science, 1995,270（5235）:397⁃403. doi: 10.1126/science.270.5235.397. |
| ［13］ | Burgos R, Pich OQ, Ferrer⁃Navarro M, et al. Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal⁃organelle development［J］. J Bacteriol, 2006,188（24）:8627⁃8637. doi: 10. 1128/JB.00978⁃06. |
| ［14］ | Li L, Krishnan M, Baseman JB, et al. Molecular cloning, expression, and characterization of a Ca2+⁃dependent, membrane⁃associated nuclease of Mycoplasma genitalium［J］. J Bacteriol, 2010,192（19）:4876⁃4884. doi: 10.1128/JB.00401⁃10. |
| ［15］ | Christodoulides A, Gupta N, Yacoubian V, et al. The role of lipoproteins in Mycoplasma⁃mediated immunomodulation［J］. Front Microbiol, 2018,9:1682. doi: 10.3389/fmicb.2018.01682. |
| ［16］ | Burgos R, Wood GE, Iverson⁃Cabral SL, et al. Mycoplasma genitalium nonadherent phase variants arise by multiple mechanisms and escape antibody⁃dependent growth inhibition［J］. Infect Immun, 2018,86（4）. doi: 10.1128/IAI.00866⁃17. |
| ［17］ | Arfi Y, Minder L, Di Primo C, et al. MIB⁃MIP is a mycoplasma system that captures and cleaves immunoglobulin G［J］. Proc Natl Acad Sci U S A, 2016,113（19）:5406⁃5411. doi: 10.1073/pnas.1600546113. |
| ［18］ | McAuliffe L, Ellis RJ, Miles K, et al. Biofilm formation by mycoplasma species and its role in environmental persistence and survival［J］. Microbiology （Reading）, 2006,152（Pt 4）:913⁃922. doi: 10.1099/mic.0.28604⁃0. |
| ［19］ | Li Y, Su X, Le W, et al. Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance［J］. Clin Infect Dis, 2020,70（5）:805⁃810. doi: 10. 1093/cid/ciz294. |
| ［20］ | Shipitsyna E, Kularatne R, Golparian D, et al. Mycoplasma genitalium prevalence, antimicrobial resistance⁃associated mutations, and coinfections with non⁃viral sexually transmitted infections in high⁃risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019 -2021［J］. Front Microbiol, 2023,14:1130762. doi: 10.3389/fmicb.2023.1130762. |
| ［21］ | Aboud S, Buhalata SN, Onduru OG, et al. High prevalence of Sexually Transmitted and Reproductive Tract Infections （STI/RTIs） among patients attending STI/Outpatient department clinics in Tanzania［J］. Trop Med Infect Dis, 2023,8（1）. doi: 10.3390/tropicalmed8010062. |
| ［22］ | Baumann L, Cina M, Egli⁃Gany D, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta⁃analysis［J］. Sex Transm Infect, 2018,94（4）:255⁃262. doi: 10.1136/sextrans⁃2017⁃053384. |
| ［23］ | 宣岩, 魏兰馨, 洪翔, 等. 我国不同人群生殖支原体感染率的Meta分析［J］. 中华流行病学杂志, 2021,42（2）:335⁃342. doi: 10.3760/cma.j.cn112338⁃20200530⁃00791. |
| ［24］ | Cina M, Baumann L, Egli⁃Gany D, et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta⁃analysis［J］. Sex Transm Infect, 2019,95（5）:328⁃335. doi: 10.1136/sextrans⁃2018⁃053823. |
| ［25］ | Balkus JE, Manhart LE, Jensen JS, et al. Mycoplasma genitalium infection in Kenyan and US Women［J］. Sex Transm Dis, 2018,45（8）:514⁃521. doi: 10.1097/OLQ.0000000000000799. |
| ［26］ | Latimer RL, Vodstrcil L, De Petra V, et al. Extragenital Mycoplasma genitalium infections among men who have sex with men［J］. Sex Transm Infect, 2020,96（1）:10⁃18. doi: 10.1136/sextrans⁃2019⁃054058. |
| ［27］ | Sonnenberg P, Ison CA, Clifton S, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16 - 44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles （Natsal⁃3）［J］. Int J Epidemiol, 2015,44（6）:1982⁃1994. doi: 10.1093/ije/dyv194. |
| ［28］ | Bissessor M, Tabrizi SN, Bradshaw CS, et al. The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men［J］. Clin Microbiol Infect, 2016,22（3）:260⁃265. doi: 10.1016/j.cmi.2015. 11.016. |
| ［29］ | Francis SC, Kent CK, Klausner JD, et al. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005 -2006［J］. Sex Transm Dis, 2008,35（9）:797⁃800. doi: 10.1097/OLQ.0b013e 318177ec39. |
| ［30］ | Ong JJ, Aung E, Read T, et al. Clinical characteristics of anorectal Mycoplasma genitalium infection and microbial cure in men who have sex with men［J］. Sex Transm Dis, 2018,45（8）:522⁃526. doi: 10.1097/OLQ.0000000000000793. |
| ［31］ | Ito S, Tsuchiya T, Yasuda M, et al. Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years⁃of⁃age with acute epididymitis［J］. Int J Urol, 2012,19（3）:234⁃238. doi: 10.1111/j.1442⁃2042.2011.02917.x. |
| ［32］ | Krieger JN, Riley DE, Roberts MC, et al. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis［J］. J Clin Microbiol, 1996,34（12）:3120⁃3128. doi: 10.1128/jcm.34.12. 3120⁃3128.1996. |
| ［33］ | Mo X, Zhu C, Gan J, et al. Prevalence and correlates of Mycoplasma genitalium infection among prostatitis patients in Shanghai, China［J］. Sex Health, 2016,doi: 10.1071/SH15155. |
| ［34］ | Ahmadi MH, Mirsalehian A, Gilani M, et al. Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium［J］. Infection, 2018,46（1）:31⁃38. doi: 10.1007/s15010⁃017⁃1075⁃3. |
| ［35］ | Huang C, Zhu HL, Xu KR, et al. Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta⁃analysis［J］. Andrology, 2015,3（5）:809⁃816. doi: 10.1111/andr. 12078. |
| ［36］ | Olson E, Gupta K, Van Der Pol B, et al. Mycoplasma genitalium infection in women reporting dysuria: a pilot study and review of the literature［J］. Int J STD AIDS, 2021,32（13）:1196⁃1203. doi: 10.1177/09564624211030040. |
| ［37］ | Lewis J, Horner PJ, White PJ. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: evidence synthesis of cohort study data［J］. Clin Infect Dis, 2020,71（10）:2719⁃2722. doi: 10.1093/cid/ciaa419. |
| ［38］ | Latimer RL, Read T, Vodstrcil LA, et al. Clinical features and therapeutic response in women meeting criteria for presumptive treatment for pelvic inflammatory disease associated with Mycoplasma genitalium［J］. Sex Transm Dis, 2019,46（2）:73⁃79. doi: 10.1097/OLQ.0000000000000924. |
| ［39］ | Frenzer C, Egli⁃Gany D, Vallely LM, et al. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta⁃analysis［J］. Sex Transm Infect, 2022,98（3）:222⁃227. doi: 10.1136/sextrans⁃2021⁃055352. |
| ［40］ | Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021［J］. MMWR Recomm Rep, 2021,70（4）:1⁃187. doi: 10.15585/mmwr.rr7004a1. |
| ［41］ | The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine （ASHM）. Australian STI management guidelines for use in primary care［EB/OL］. ［2023⁃07⁃20］. https://sti.guidelines.org.au/sexually⁃transmissible⁃infections/mycoplasma⁃genitalium/. |
| ［42］ | Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium （2018）［J］. Int J STD AIDS, 2019,30（10）:938⁃950. doi: 10.1177/0956462419825948. |
| ［43］ | Jensen JS, Björnelius E, Dohn B, et al. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic［J］. Sex Transm Dis, 2004,31（8）:499⁃507. doi: 10.1097/01.olq.0000135992.98883.e4. |
| ［44］ | Gaydos CA, Manhart LE, Taylor SN, et al. Molecular testing for Mycoplasma genitalium in the United States: results from the AMES prospective multicenter clinical study［J］. J Clin Microbiol, 2019,57（11）:e01125⁃01119. doi: 10.1128/JCM.01125⁃19. |
| ［45］ | Peris MP, Dehesa B, Alonso H, et al. Retrospective and comparative study of three molecular assays for the macrolide resistance detection in Mycoplasma genitalium positive urogenital specimens［J］. Int J Mol Sci, 2023,24（8）:7218. doi: 10.3390/ijms24087218. |
| ［46］ | Fernández⁃Huerta M, Bodiyabadu K, Esperalba J, et al. Multicenter clinical evaluation of a novel multiplex real⁃time PCR （qPCR） assay for detection of fluoroquinolone resistance in Mycoplasma genitalium［J］. J Clin Microbiol, 2019,57（11）:e00886⁃19. doi: 10.1128/JCM.00886⁃19. |
| ［47］ | Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment［J］. J Infect Dis, 2017,216（suppl_2）:S412⁃S419. doi: 10.1093/infdis/jix132. |
| ［48］ | Abavisani M, Keikha M. Global analysis on the mutations associated with multidrug⁃resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta⁃analysis［J］. Ann Clin Microbiol Antimicrob, 2023,22（1）:70. doi: 10. 1186/s12941⁃023⁃00627⁃6. |
| ［49］ | Ke W, Li D, Tso LS, et al. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016 -2018［J］. BMC Infect Dis, 2020,20（1）:950. doi: 10.1186/s12879⁃020⁃05659⁃3. |
| ［50］ | Wang L, Li Z, Wan C, et al. Prevalence of Mycoplasma genitalium infection with antimicrobial resistance mutations among gay sex workers in China［J］. Int J STD AIDS, 2023,34（8）:518⁃524. doi: 10.1177/09564624231160676. |
| ［51］ | Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium⁃infected cohort and response of azithromycin failures to alternative antibiotic regimens［J］. Clin Infect Dis, 2015,60（8）:1228⁃1236. doi: 10.1093/cid/ciu1162. |
| ［52］ | Murray GL, Bodiyabadu K, Vodstrcil LA, et al. parC Variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure［J］. Antimicrob Agents Chemother, 2022,66（5）:e0027822. doi: 10.1128/aac.00278⁃22. |
| ［53］ | Murray GL, Bodiyabadu K, Danielewski J, et al. Moxifloxacin and sitafloxacin treatment failure in Mycoplasma genitalium infection: association with parC mutation G248T （S83I） and concurrent gyrA mutations［J］. J Infect Dis, 2020,221（6）:1017⁃1024. doi: 10.1093/infdis/jiz550. |
| ［54］ | 袁梦瑾. MG感染耐药性和治疗的研究［D］. 北京: 北京协和医学院, 2023. |
| ［55］ | Read T, Fairley CK, Murray GL, et al. Outcomes of resistance⁃guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation［J］. Clin Infect Dis, 2019,68（4）:554⁃560. doi: 10.1093/cid/ciy477. |
| ［56］ | Durukan D, Read T, Murray G, et al. Resistance⁃guided antimicrobial therapy using doxycycline⁃moxifloxacin and doxycycline⁃2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability［J］. Clin Infect Dis, 2020,71（6）:1461⁃1468. doi: 10.1093/cid/ciz1031. |
| ［57］ | Durukan D, Doyle M, Murray G, et al. Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium［J］. Emerg Infect Dis, 2020,26（8）:1870⁃1874. doi: 10.3201/eid2608.191806. |
| ［58］ | 李赛, 薛华忠, 张树文, 等. 多西环素⁃莫西沙星序贯疗法治疗生殖支原体尿道炎/宫颈炎的临床观察［J］. 中华皮肤科杂志, 2022,55（12）:1092⁃1095. doi: 10.35541/cjd.20210631. |
| ［59］ | Li L, Yuan Y, He W, et al. Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China［J］. Diagn Microbiol Infect Dis, 2023,105（2）:115854. doi: 10.1016/j.diagmicrobio.2022.115854. |
| ［60］ | Ando N, Mizushima D, Takano M, et al. Effectiveness of sitafloxacin monotherapy for quinolone⁃resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study［J］. J Antimicrob Chemother, 2023,78（8）:2070⁃2079. doi: 10.1093/jac/dkad208. |
| ［61］ | Doyle M, Vodstrcil LA, Plummer EL, et al. Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance［J］. Open Forum Infect Dis, 2020,7（8）:ofaa291. doi: 10.1093/ofid/ofaa291. |
| ［62］ | Clarke EJ, Vodstrcil LA, Plummer EL, et al. Efficacy of minocycline for the treatment of Mycoplasma genitalium［J］. Open Forum Infect Dis, 2023,10（8）:ofad427. doi: 10.1093/ofid/ofad427. |
| ［63］ | Glaser AM, Geisler WM, Ratliff AE, et al. Two cases of multidrug⁃resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline［J］. Int J STD AIDS, 2019,30（5）:512⁃514. doi: 10.1177/0956462418816757. |
| ［64］ | Read T, Jensen JS, Fairley CK, et al. Use of pristinamycin for macrolide⁃resistant Mycoplasma genitalium infection［J］. Emerg Infect Dis, 2018,24（2）:328⁃335. doi: 10.3201/eid2402.170902. |
| ［65］ | Falk L, Enger M, Jensen JS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women［J］. J Antimicrob Chemother, 2015,70（11）:3134⁃3140. doi: 10.1093/jac/dkv246. |
| [1] | 刘佳 谷映桦 贺小宁. 遗传性血管性水肿治疗方式与疾病负担研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 282-286. |
| [2] | 曾莞欣 文翔. 增生性瘢痕的光电治疗进展[J]. 中华皮肤科杂志, 2026, 59(3): 269-273. |
| [3] | 范慧琳 赵慧敏 彭依然 汪犇 黄莹雪 赵志祥 唐言 简丹. 低能量CO2点阵激光治疗玫瑰痤疮难治性持续性红斑的回顾性研究[J]. 中华皮肤科杂志, 2026, 59(3): 218-223. |
| [4] | 朱芸 王建才 杨明 顾菲 张洪丽 高莹. 755 nm皮秒激光治疗儿童咖啡牛奶斑的疗效及影响因素分析[J]. 中华皮肤科杂志, 2026, 59(3): 224-229. |
| [5] | 夏志宽 葛格. [开放获取] 白癜风激光治疗临床应用与展望[J]. 中华皮肤科杂志, 2026, 59(3): 213-217. |
| [6] | 中华医学会皮肤性病学分会银屑病专业委员会. 伴共病的银屑病管理共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(3): 193-207. |
| [7] | “Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology ”解读专家组 中华医学会皮肤性病学分会激光学组. [开放获取] 2025版光生物调节疗法在皮肤科的临床应用中国专家共识要点解读[J]. 中华皮肤科杂志, 2026, 59(3): 208-212. |
| [8] | 王钧程 刘洁. [开放获取] 人工智能在银屑病临床诊疗与患者管理中的应用进展[J]. 中华皮肤科杂志, 2026, 0(3): 20240061-e20240061. |
| [9] | 王丽 王千秋 张瑞丽. 隐性梅毒研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 286-289. |
| [10] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会. [开放获取] 中国皮炎湿疹类疾病诊疗指南（2026版）[J]. 中华皮肤科杂志, 2026, 59(2): 97-106. |
| [11] | 中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组 中国老年保健医学研究会皮肤科分会 中国中药协会皮肤病药物研究专业委员会 中国人体健康科技促进会皮肤科分会. 保湿剂在特应性皮炎管理中的合理应用专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(2): 107-112. |
| [12] | 陈浩. 几种新的皮肤软组织肿瘤及亚型的临床组织学特点[J]. 中华皮肤科杂志, 2026, 59(2): 120-126. |
| [13] | 郝峰 左墨 范尊卿 谢凯 王红蕾 王学庆 陈声利 陈学超 刘国艳. 光学相干断层扫描技术辅助基底细胞癌诊断的临床研究[J]. 中华皮肤科杂志, 2026, 59(2): 155-160. |
| [14] | 许国康 蔡梅. 索立德吉治疗局部晚期基底细胞癌8例临床分析[J]. 中华皮肤科杂志, 2026, 59(2): 166-169. |
| [15] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会 中国医疗保健国际交流促进会皮肤医学分会 中国罕见病联盟皮肤罕见病专业委员会. [开放获取] 佩索利单抗治疗炎症性皮肤病专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(2): 113-119. |
|
